| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.05▲ | 3.09▼ | 3.09▼ | 3.12▼ | 2.98▲ |
| MA10 | 3.07▼ | 3.09▼ | 3.09▼ | 3.08▼ | 3.19▼ |
| MA20 | 3.08▼ | 3.09▼ | 3.10▼ | 2.99▲ | 3.32▼ |
| MA50 | 3.08▼ | 3.10▼ | 3.10▼ | 3.21▼ | 3.18▼ |
| MA100 | 3.10▼ | 3.09▼ | 3.00▲ | 3.32▼ | 3.41▼ |
| MA200 | 3.11▼ | 2.99▲ | 3.00▲ | 3.17▼ | 4.33▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.002▼ | -0.006▼ | 0.034▲ | -0.053▼ |
| RSI | 41.233▼ | 40.811▼ | 44.813▼ | 48.197▼ | 46.515▼ |
| STOCH | 11.352▼ | 64.872 | 43.698 | 84.480▲ | 14.375▼ |
| WILL %R | -70.588 | -70.588 | -78.261▼ | -28.916 | -77.419▼ |
| CCI | -55.163 | -140.426▼ | -161.144▼ | 40.739 | -61.715 |
| RSI | $AVIR RSI(14) Crossed Below 50 | Set Alert |
|
Tuesday, October 07, 2025 05:17 AM
Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
|
|
Tuesday, October 07, 2025 05:05 AM
BOSTON, Oct. 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for ...
|
|
Wednesday, September 24, 2025 05:00 PM
Rhumbline Advisers reduced its position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) by 10.3% during the first quarter, according to the company in its most recent filing with the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/10/25 | 3.10 | 3.12 | 3.035 | 3.06 | 390,652 |
| 16/10/25 | 3.14 | 3.1699 | 3.075 | 3.12 | 282,990 |
| 15/10/25 | 3.13 | 3.1739 | 3.045 | 3.15 | 445,886 |
| 14/10/25 | 3.08 | 3.165 | 3.02 | 3.14 | 314,956 |
| 13/10/25 | 3.14 | 3.1458 | 3.005 | 3.11 | 295,306 |
| 10/10/25 | 3.13 | 3.1684 | 2.9935 | 3.14 | 360,086 |
| 09/10/25 | 3.10 | 3.16 | 3.08 | 3.13 | 374,426 |
| 08/10/25 | 3.01 | 3.10 | 2.96 | 3.10 | 1,154,417 |
| 07/10/25 | 2.91 | 3.055 | 2.895 | 2.97 | 1,045,004 |
| 06/10/25 | 2.90 | 2.935 | 2.84 | 2.91 | 475,959 |
|
|
||||
|
|
||||
|
|